Active investors writing cheques at this stage, from the Cut Through Venture investor database.
This page lists investors from the Cut Through Venture investor database that invest at Series C and beyond, including global growth equity firms, crossover funds and strategic investors that have backed Australian companies at scale.
Late stage capital is where Australian funding totals are made or broken. In Q2 2026 the two largest rounds, a $725M strategic round and a $460M Series H, made up close to 70% of all capital raised, and the top 20 deals took 95%. Investor-reported Series C+ valuations averaged $158M in that quarter. Late stage rounds are few, but they are large, and most involve at least one international investor.
Use the filters to find funds active in your sector, and see the latest quarterly report for the largest deals and the investors behind them.
Acorn Capital is a Melbourne-based fund manager that invests from Series A through to growth rounds. It runs multiple vehicles, including a listed investment fund and microcap funds, and its recent deals span fintech, life sciences and biotech, and vertical and horizontal business software. Recent investments include Liquid Instruments and Conflux Technology.
View profileAfterWork Ventures is a Sydney-based angel network that invests from pre-seed through to later growth rounds. It is sector agnostic, backing the right team over any specific vertical, and its recent deals span vertical software, marketplaces, fintech and healthtech, drawing on a community of 100+ tech operators. Recent investments include Enrola and Lyka Pet Food.
View profileAirTree Ventures is a Sydney-based venture capital fund that invests from pre-seed through to growth-stage rounds. Its recent deals span fintech, healthtech, education and vertical software, and it announced a $250 million seed fund alongside a $400 million growth fund in 2025. Recent investments include High Earth Orbit Robotics and Gridsight.
View profileAlberts Impact Ventures is a Sydney-based impact fund that invests from seed through to later growth rounds. It backs companies across equality, culture, healthy minds and sustainable environment themes, with recent deals spanning marketplaces, vertical software, climate and energy, and life sciences and biotech, and combines venture investing with philanthropy through the Tony Foundation. Recent investments include Sendle and Bygen.
View profileAlium Capital is a Sydney-based growth and private equity investor that invests from pre-seed through to later-stage rounds. Founded in 2016, it invests in private, secondary and public technology companies across Australia and New Zealand, with recent deals spanning consumer tech, education, fintech and vertical software, and has recorded nearly 40 exits since inception. Recent investments include Quantum Brilliance and Atmo Biosciences.
View profileArchangel Ventures is a Sydney-based venture capital fund that invests from pre-seed through to later growth rounds. It backs companies across Australia and South East Asia, with recent deals spanning healthtech, vertical software, education and fintech, and is currently deploying its 2026 Fund. Recent investments include Sophiie and Refresh.
View profileArtesian is a Sydney-based venture capital fund, founded in 2004, that invests from pre-seed through to growth rounds. It manages roughly $1.5 billion across debt and venture platforms, with recent deals spanning life sciences and biotech, cybersecurity, space and defence, and healthtech, and has backed more than 600 ventures under founders Jeremy Colless and Matt Clunies-Ross. Recent investments include Elita and Strong Room AI.
View profileAura Ventures is a Sydney-based venture capital fund, founded in 2013, that invests from pre-seed through to growth rounds. It takes a thesis-driven approach across Australia and South East Asia, with recent deals spanning marketplaces, vertical software, consumer tech and fintech. Recent investments include Isaacus and Haast.
View profileBailador is a Sydney-based listed investment company that invests from Series A through to later growth rounds. As Bailador Technology Investments on the ASX, it writes $5 million to $20 million equity checks into companies with proven business models, with recent deals spanning horizontal and vertical business software, healthtech and fintech. Recent investments include DASH Technology Group and Rosterfy.
View profileBlackbird is a Sydney-based venture capital fund that invests from pre-seed through to growth-stage rounds. It backs companies across Australia and New Zealand, with a portfolio valued at more than $10 billion across 100+ companies, and recent deals spanning hardware and robotics, consumer brands, healthtech and vertical software. Recent investments include OpenDebt and Heidi Health.
View profileBlack Sheep Capital is a Brisbane-based angel network, founded in 2013 by Dan Gavel, that backs pre-seed through to Series A companies. It writes cheques from $100,000 to $500,000 depending on stage, with recent deals spanning horizontal and vertical business software, fintech and consumer tech, and its 22 active investments have collectively raised more than $290 million. Recent investments include Visaible.ai and Haast.
View profileBrandon Capital is a Melbourne-based venture capital fund that invests from seed through to growth rounds. Founded by Chris Nave and Stephen Thompson, it focuses on life sciences and biotech, healthtech and consumer tech, and closed its Fund Six at more than $430 million in 2025 with a $150 million commitment from the National Reconstruction Fund Corporation. Recent investments include AdvanCell Isotopes and Lumonus.
View profileBreakthrough Victoria is a Melbourne-based government-owned investment fund, launched in 2021, that invests from pre-seed through to growth capital rounds. Owned by the Victorian Government, it provides patient capital across advanced manufacturing, clean economy, digital technologies and health and life sciences, with recent deals spanning hardware and robotics, climate and energy, education and life sciences and biotech. Recent investments include GonGlobal and Amber Electric.
View profileCarthona Capital is a venture capital fund based in Sydney, investing from seed through to Series B and beyond. It backs companies across fintech, climate and energy, and hardware and robotics, and has raised a third fund of roughly $360 million from super funds, family offices and high net worth investors. Recent investments include Safewill and BuildPass.
View profileCo:Act Capital is a venture capital fund based in Sydney, investing from seed through Series B and beyond with a focus on Series A. It backs hardware and robotics, fintech, healthtech and vertical software companies, and emphasises responsible investing aligned to the UN Sustainable Development Goals. Recent investments include EatClub and Vantari VR.
View profileCultiv8 Funds Management is an impact fund based in Sydney, investing from seed through to Series B. It specialises in agri-food technology, covering vertical business software and hardware and robotics, and typically writes initial cheques of $500,000 to $3 million. Recent investments include Farmbot and ExoFlare.
View profileEVP is a venture capital fund based in Sydney, investing from seed through Series A and beyond. It backs B2B software companies across vertical and horizontal software, fintech and marketplaces, and closed its Fund V at $100 million in 2025. Recent investments include AutoGrab and CorePlan.
View profileFive V Capital is a growth and private equity investor based in Sydney, investing from seed through to growth rounds. It backs horizontal business software, fintech, cybersecurity and space and defence companies, with its venture arm writing $1 million to $10 million cheques into Series A and B software companies. Recent investments include Ordermentum and Lyrebird Health.
View profileFlying Fox Ventures is a venture capital fund based in Melbourne, founded in 2017 and backing pre-seed through Series B companies. It invests across horizontal and vertical business software, life sciences and biotech, and fintech, drawing on a large angel investor community and a $20 million fund with more than 100 portfolio companies. Recent investments include Operata and Safewill.
View profileFolklore is a venture capital fund based in Sydney, backing pre-seed through Series B companies. It invests across healthtech, vertical and horizontal business software and fintech, and follows a long-term partnership model supporting Australian and New Zealand founders from first cheque onward. Recent investments include Arkeus and Hullbot.
View profileGalileo Ventures is a venture capital fund based in Sydney, founded in 2020 and backing pre-seed and seed companies. It invests across vertical business software, healthtech, AI infrastructure and hardware and robotics, with offices in Sydney, Melbourne and San Francisco and typical cheques of $200,000 to $500,000. Recent investments include Relevance AI and Isaacus.
View profileGandel Invest is a family office based in Melbourne, investing from seed through growth equity and Series B rounds. It backs marketplace, vertical business software, consumer brand and fintech companies as part of the Gandel family's broader investment activities. Recent investments include pay.com.au and EatClub.
View profileGiant Leap is an impact fund based in Melbourne, founded in 2016 and investing from pre-seed through to Series B. It backs hardware and robotics, marketplace, education and consumer brand companies across climate, health and social-impact themes, and holds an AFSL for its 30 plus portfolio companies. Recent investments include Teacher's Buddy and indi.
View profileGrok Ventures is the family office of Mike and Annie Cannon-Brookes, based in Sydney and investing from seed through to Series B and beyond. It focuses on fintech, climate and energy, consumer brands and life sciences, and pivoted to a climate technology investment mandate around 2021. Recent investments include Fleet and Spriggy.
View profileIAG Firemark Ventures is the corporate venture capital arm of IAG, based in Sydney and backing seed through growth-stage strategic investments. It focuses on cybersecurity, space and defence, vertical business software and fintech, and launched a second $75 million fund as part of the Firemark Collective. Recent investments include Sonder and Myriota.
View profileInterValley Ventures is a venture capital fund based in Sydney, founded in 2019 and backing seed through Series B companies. It invests across life sciences, hardware and robotics, cybersecurity and consumer tech, and is affiliated with Mizuho Financial Group to help portfolio companies expand into Japan. Recent investments include QuintessenceLabs and Quantum Brilliance.
View profileInvestible is a venture capital fund based in Sydney, founded in 2018 and investing from pre-seed through Series A with capacity to follow on. It backs marketplace, vertical and horizontal business software and fintech companies from offices in Sydney and Singapore, and runs Club Investible, a syndicate of more than 250 co-investors. Recent investments include Apate AI and PlasmaLeap Technologies.
View profileIP Group is a university-linked investor based in London, founded in 2001 and backing seed through Series B companies. It commercialises intellectual property from universities across hardware and robotics, life sciences, cybersecurity and climate and energy, and expanded into Australia in 2017 with $100 million committed alongside the Group of Eight universities. Recent investments include amsl aero and Hysata.
View profileKing River is a Sydney-based venture capital fund investing from Series A through to Series B and beyond. Its recent deals span consumer tech, vertical business software, crypto and web3, and fintech, and it launched a $150 million AI-focused fund in March 2025. Recent investments include Block Earner and Sendle.
View profileLarsen Ventures is a Sydney-based venture capital fund investing across the full range from pre-seed and seed through to Series A and Series B and beyond. Its recent deals span education, fintech, hardware and robotics, and consumer brands, and it is associated with investor Andrew Larsen's family office. Recent investments include Go1 and Bare.
View profileMacdoch Ventures is a Sydney-based venture capital fund investing from pre-seed and seed through to Series A and Series B and beyond. Its recent deals span marketplaces, horizontal business software, fintech and climate and energy, and it operates as part of the broader Macdoch Group family office. Recent investments include Farmbot and Brainfish.
View profileMain Sequence is a Sydney-based venture capital fund, founded in 2017, investing from pre-seed and seed through to Series A and Series B and beyond. Its recent deals span climate and energy, hardware and robotics, space and defence and AI infrastructure, and it spun out of CSIRO, Australia's national science agency, raising a $450 million third fund in 2022. Recent investments include Kinoxis Therapeutics and Avarni.
View profileMarbruck Investments is a Sydney-based venture capital fund investing at Series A and Series B and beyond. Its recent deals span climate and energy, vertical business software and horizontal business software, and it operates as an open-ended group with offices in Darlinghurst, Sydney and Causeway Bay, Hong Kong. Recent investments include EatClub and Sitemate.
View profileOIF Ventures is a Sydney-based venture capital fund investing across the full range from pre-seed and seed through to growth stage. Its recent deals span marketplaces, vertical business software, education and fintech, and it manages over $500 million in assets through a network of 150 investors. Recent investments include Advanced Navigation and Mary Technology.
View profileOneVentures is a Sydney-based venture capital fund investing at Series A and Series B and beyond. Its recent deals span healthtech, life sciences and biotech, marketplaces and vertical business software, and it manages $1 billion or more in assets across growth equity, growth credit and healthcare investment pillars. Recent investments include Vaxxas and Employment Hero.
View profilePipeline Capital is a Gold Coast-based venture debt provider investing from pre-seed and seed through to Series B and beyond. Its recent deals span hardware and robotics, vertical business software, marketplaces and cybersecurity, and it combines capital with mentorship and strategic support for entrepreneurs. Recent investments include GreaseBoss and Console Group.
View profileProto Axiom is a Sydney-based venture capital fund, founded in 2021, investing from seed through to Series A and Series B and beyond. Its recent deals are concentrated in life sciences and biotech, and it operates a company-creation model, building the companies it invests in using permanent capital and running the related Women's Health Foundry. Recent investments include AdvanCell Isotopes and JumpStart Fertility.
View profileRadar Ventures is a venture capital fund based in Sydney, investing at seed through Series B+ stages. It focuses on deep tech and platform technologies, with recent deals spanning hardware, robotics and sensors and life sciences and biotech, and Xero co-founder Rod Drury serves as general partner. Recent investments include OncoRes Medical and Cortical Labs.
View profileRampersand is a venture capital fund based in Melbourne, founded in 2013, investing from pre-seed through Series B+. Its recent deals span fintech, marketplace, horizontal business software and life sciences and biotech, and it has deployed over $100 million across 4 funds since inception. Recent investments include Parachute and Cuttable.
View profileREA Group is a corporate venture capital investor based in Melbourne, investing from Series A through growth and strategic investment stages. It is the ASX-listed operator of realestate.com.au and makes strategic investments in proptech and adjacent fintech businesses. Recent investments include Athena and Agtuary.
View profileRegal Funds Management is a growth and private equity investor based in Sydney, founded in 2004, backing companies from Series A through growth and Series B+ rounds. Its deals span fintech, marketplace, healthtech and vertical business software, run through a private markets and pre-IPO strategy under parent company Regal Partners Limited. Recent investments include Superhero and Send Payments.
View profileReinventure Group is a corporate venture capital firm based in Sydney, investing from pre-seed through Series B+ and strategic investment stages. Its recent deals span horizontal business software, cybersecurity, compliance and digital identity, vertical business software and fintech, backed by around $150 million with Westpac Banking Corporation as its largest limited partner. Recent investments include Kasada and Instant.
View profileRFC Ambrian is a growth and private equity firm based in Sydney, founded in 1985, backing companies at seed and Series B+ stages. It focuses on critical minerals, critical technologies, natural resources and heavy industry, with deals spanning hardware, robotics and sensors and climate and energy. Recent investments include MagnaTerra Technologies and NextOre.
View profileSalus Ventures is a venture capital fund based in Sydney, investing from pre-seed through Series B+. It runs a $40 million fund focused on sovereign and national-security capabilities, with deals spanning vertical business software, space and defence, hardware, robotics and sensors and healthtech. Recent investments include High Earth Orbit Robotics and Arkeus.
View profileSecondQuarter Ventures is a Sydney-based secondaries fund, investing at seed through Series B+. It specialises in venture secondaries, providing liquidity to founders and early investors in Australian and New Zealand tech companies, with deals spanning marketplace, vertical business software, horizontal business software and education and training. Recent investments include Sonder and ProcurePro.
View profileShearwater Capital is a growth and private equity investor based in Sydney, founded in 2018, backing companies from pre-seed through Series B+. It invests roughly $100 million of its 3 founder-partners' own capital across hardware, robotics and sensors, vertical business software, life sciences and biotech and horizontal business software. Recent investments include Parallel and Factory.
View profileSignificant Capital Ventures is a venture capital fund based in Canberra, investing since 2000 at seed through Series B+ stages. It focuses on critical and applied technologies spanning climate and energy, healthtech, space and defence and hardware, robotics and sensors, with 32 investments across 3 funds and 21 SPV syndicates. Recent investments include Liquid Instruments and Visionary Machines.
View profileSkip Capital is a family office based in Sydney, investing from pre-seed through Series B+. It is the private investment fund of Atlassian co-founder Scott Farquhar and Kim Jackson, with deals spanning hardware, robotics and sensors, consumer brands, vertical business software and fintech. Recent investments include Alloy and MicroTau.
View profileSquare Peg is a venture capital fund based in Melbourne, founded in 2012, investing from pre-seed through Series B+. The firm manages billions of US dollars in assets under management, backing deals across fintech, life sciences and biotech, healthtech and vertical business software in Australia, New Zealand, Southeast Asia and Israel. Recent investments include Alloy and Constantinople.
View profileStarfish Ventures is a venture capital fund based in Melbourne, investing at seed through Series B+ stages. It backs growth-stage ICT, life sciences and cleantech businesses spanning marketplace and vertical business software, and has closed funds taking total funds under management to over $385 million. Recent investments include H3D and DesignCrowd.
View profileStartmate is an accelerator based in Sydney, founded in 2010 by Niki Scevak, investing from pre-seed through Series B+. It runs cohort-based programs across marketplace, vertical business software, horizontal business software and climate and energy, with a portfolio of over 350 companies valued at a combined $4.5 billion. Recent investments include EstiMate AI and GlowBack.
View profileStoic Venture Capital is a university-linked investor based in Sydney, founded in 2019, investing from pre-seed through Series B+. It describes itself as Australia's first university-focused venture fund, backing life sciences and biotech, hardware, robotics and sensors and climate and energy with cheques of roughly $100,000 to $1 million. Recent investments include Kinoxis Therapeutics and Ena Respiratory.
View profileTall Order Ventures, formerly Skalata Ventures, is a venture capital fund based in Melbourne, investing from pre-seed through Series B+. It describes itself as a first-cheque fund backing AI-native founders across vertical business software, horizontal business software, education and training and marketplace sectors, and is raising Fund III with cheques up to $1 million. Recent investments include Enrola and Viewa.
View profileTaronga Group is a venture capital fund based in Sydney, investing from seed through Series A and Series B+ rounds. Founded in 2015 by Avi Naidu and Jonathan Hannam, it focuses on 'RealTech' investing across vertical and horizontal business software, hardware and robotics, and climate and energy. Recent investments include Kraken Technologies and Plante.
View profileTEN13 is a venture syndicate based in Brisbane, investing from angel and pre-seed through seed, Series A and Series B+ rounds. Founded by Steve Baxter and Stew Glynn, it has deployed more than $125 million since 2019 across deals spanning vertical business software, education, marketplaces and consumer brands. Recent investments include Bower and AutoGrab.
View profileTenmile is a venture capital fund based in Perth, investing from seed through Series A and Series B+ rounds. Launched by Andrew Forrest's Tattarang in 2022 with $250 million in committed capital, it backs health technology companies across life sciences and biotech and healthtech. Recent investments include AdvanCell and Mindset Health.
View profileTidal Ventures is a venture capital fund based in Sydney, investing from angel and pre-seed through seed, Series A and Series B+ rounds. It focuses on AI companies reshaping how work gets done, backing vertical and horizontal business software, healthtech and AI infrastructure across Australia and the US. Recent investments include Operata and Checkbox.
View profileTin Alley Ventures is a university-linked venture fund based in Melbourne, investing from seed through to accelerator and Series B+ stages. Created by the University of Melbourne with Tanarra Capital, it manages $125 million backing deep tech spinouts across horizontal business software, climate and energy, life sciences and biotech and AI infrastructure. Recent investments include Apromore and Proxima Bio.
View profileTitanium Ventures is a venture capital fund based in San Francisco, investing at Series A and Series B+ stages. Formerly Telstra Ventures, it has operated for more than 12 years with additional offices in Sydney, Melbourne and London, backing hardware and robotics, education, horizontal business software and climate and energy companies. Recent investments include Samsara and Silicon Quantum Computing.
View profileTouch Ventures is an ASX-listed investment company based in Sydney, backing companies from seed through Series A and Series B+ rounds. It provides growth capital of $3 million to $10 million across marketplaces, vertical business software, cybersecurity and fintech, investing both locally and offshore. Recent investments include Sendle and Ordermentum.
View profileUniseed is a university-linked investor based in Brisbane, investing from angel and pre-seed through seed, Series A and Series B+ rounds. Founded in 2000 and jointly owned by nine Australian universities plus CSIRO, it has backed more than 70 companies across life sciences and biotech, hardware and robotics, climate and energy and vertical business software. Recent investments include Ferronova and DeteQt.
View profileUniversity of Melbourne is a university-linked investor based in Melbourne, backing companies from angel and pre-seed through seed, Series A and Series B+ rounds via its research commercialisation office. It co-launched the $15 million Genesis Pre-Seed Fund with Breakthrough Victoria and backs deals across life sciences and biotech, horizontal business software, hardware and robotics and healthtech. Recent investments include Kali Healthcare and PredicTx Health.
View profileUniversity of New South Wales is a university-linked investor based in Sydney, backing companies from seed through accelerator, Series A and Series B+ stages via its Barker Street Ventures platform. Over the past decade, UNSW-linked ventures have attracted a cumulative $5.6 billion in capital, with deals spanning marketplaces, vertical and horizontal business software and hardware and robotics. Recent investments include High Earth Orbit Robotics and JumpStart Fertility.
View profileVirescent Ventures is a venture capital fund based in Sydney, investing from seed through Series A, Series B+ and strategic rounds. Launched by Australia's Clean Energy Finance Corporation, it manages more than $500 million and backs companies across hardware and robotics, climate and energy and life sciences and biotech. Recent investments include MicroTau and Amber Electric.
View profileWunala Capital is a growth and private equity firm based in Sydney, providing late-stage capital at Series B and beyond. It manages the Wunala Capital Emerging Opportunities Fund, offering bridge and pre-IPO financing across horizontal business software, fintech, life sciences and biotech and space and defence. Recent investments include Send Payments and Marketplacer.
View profileSeries C and later rounds fund companies that are already at scale, often preparing for international expansion, acquisitions or an eventual IPO. Investors at this stage include global growth equity firms, crossover funds, sovereign and superannuation backed funds and strategic corporate investors.
Late stage rounds are few but very large. In Q2 2026 the two biggest deals, a $725M strategic round and a $460M Series H, made up close to 70% of all capital raised in Australia, and investor-reported Series C+ valuations averaged $158M, according to Cut Through Venture data.
Most late stage rounds in Australia involve at least one international investor, often alongside a local fund that has followed the company from an earlier stage. The list on this page covers every investor in the Cut Through Venture database that invests at Series C and beyond.